The University of Chicago Header Logo

Connection

Douglas Merkel to Trastuzumab

Back to Details
This is a "connection" page, showing publications Douglas Merkel has written about Trastuzumab.
Douglas Merkel
Connection Strength
0.014
Trastuzumab
  1. Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial. J Clin Oncol. 2004 Mar 15; 22(6):1071-7.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.